Maravai LifeSciences Inc.

MRVI | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.17

+$0.20 (+2.87%)

At close: Sep 21, 2026, 4:00 PM ET

$7.30

+$0.13 (+1.81%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	185.74M	259.19M	288.95M	883M	799.24M	284.1M
Cost of Revenue	152.35M	150.88M	148.74M	168.96M	140.56M	79.65M
Gross Profit	33.39M	108.31M	140.2M	714.04M	658.68M	204.45M
Operating Income	-6.74M	-235.62M	-31.65M	574.22M	554.65M	119.9M
Interest Income	23.95M	27.4M	27.73M	2.34M	n/a	n/a
Pretax Income	-234.97M	-261.48M	617.74M	551.47M	530.77M	81.7M
Net Income	-130.77M	-144.85M	-119.03M	220.21M	182.04M	76.89M
Selling & General & Admin	171.47M	161.77M	151.39M	129.26M	100.06M	94.25M
Research & Development	23.33M	19.22M	17.28M	18.37M	15.22M	9.3M
Other Expenses	-154.67M	162.93M	3.18M	-7.8M	-11.25M	-19M
Operating Expenses	40.13M	343.93M	171.85M	139.83M	104.03M	84.55M
Interest Expense	26.99M	47.7M	45.89M	20.41M	30.26M	30.74M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	192.48M	494.8M	320.59M	308.79M	244.6M	164.2M
Income Tax Expense	-4.21M	-1.86M	756.11M	60.81M	61.52M	2.88M
Shares Outstanding (Basic)	145.07M	137.91M	131.92M	131.54M	114.79M	96.65M
Shares Outstanding (Diluted)	145.07M	137.91M	131.92M	131.7M	121.97M	96.65M
EPS (Basic)	-0.91	-1.05	-0.90	1.67	1.59	7.43
EPS (Diluted)	-0.91	-1.05	-0.90	1.67	1.56	2.36
EBITDA	-147.11M	-156.92M	712.41M	609.99M	585.78M	138.27M
EBIT	-207.98M	-213.78M	663.63M	571.89M	561.03M	112.44M
Depreciation & Amortization	60.87M	56.87M	48.78M	38.1M	24.75M	25.84M